发明名称 |
UNITARY PHARMACEUTICAL DOSAGE FORM |
摘要 |
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation. |
申请公布号 |
US2017079999(A1) |
申请公布日期 |
2017.03.23 |
申请号 |
US201615370588 |
申请日期 |
2016.12.06 |
申请人 |
BRISTOL-MYERS SQUIBB & GILEAD SCIENCES, LLC |
发明人 |
DAHL Terrence C.;HUSSAIN Munir A.;LIPPER Robert A.;JERZEWSKI Robert L.;MENNING Mark M.;OLIYAI Reza;YANG Taiyin |
分类号 |
A61K31/683 |
主分类号 |
A61K31/683 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition comprising tenofovir DF and a surfactant whereby the surfactant is in a stabilizing configuration with the tenofovir DF. |
地址 |
Foster City CA US |